Advertisement

Clinical Application of the Coronary Artery Calcium Score and Implications for Cardiovascular Disease Prevention

  • Pamela B. MorrisEmail author
  • Michael D. Shapiro
Chapter
Part of the Contemporary Medical Imaging book series (CMI)

Abstract

Cardiovascular disease continues to be the leading cause of morbidity and mortality around the globe, and CACS is an important tool to readily identify individuals at high risk of events to initiate early lifesaving preventive interventions. The assessment of subclinical coronary atherosclerosis by CACS has been shown to be a robust predictor of both near- and long-term clinical ASCVD events and provides information that outperforms traditional risk factor-based assessments. Current guidelines focus on the consideration of CACS in intermediate-risk patients to inform clinical decision making for initiation of preventive therapies. Knowledge of the subclinical disease can improve adherence to preventive medications and lifestyle interventions.

Keywords

Coronary artery calcium score Cardiovascular disease prevention Atherosclerotic cardiovascular disease risk Cardiovascular risk assessment Prediction of coronary heart disease 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics—2016 update. A report from the American Heart Association. Circulation. 2016;133:e38–e360.PubMedGoogle Scholar
  2. 2.
    Ford ES, Ajani UA, Croft JB, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med. 2007;356:2388–98.PubMedCrossRefGoogle Scholar
  3. 3.
    Greenland P, Bonow RO, Brundage BH, et al. ACCF/AHA 2007 Clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain. Circulation. 2007;115:402–26.PubMedCrossRefGoogle Scholar
  4. 4.
    Wilson PWF, D’Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837–47.PubMedCrossRefGoogle Scholar
  5. 5.
    Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study. [Erratum: Circulation. 2002;105:900]. Circulation. 2002;105:310–5.PubMedCrossRefGoogle Scholar
  6. 6.
    Conroy R, Pylorala K, Fitzgerald AP, et al. The SCORE (Systemic Coronary Risk Evaluation) manuscript. Prediction of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003;24:987–1003.PubMedCrossRefGoogle Scholar
  7. 7.
    Goff DF, Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk. J Am Coll Cardiol. 2014;63:2935–57.PubMedCrossRefGoogle Scholar
  8. 8.
    Ridker PM, Paynter NP, Rifai N, et al. C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds risk score for men. Circulation. 2008;118:2243–51.PubMedPubMedCentralCrossRefGoogle Scholar
  9. 9.
    Ridker PM, Buring JE, Firai N, Cook NR. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk score. JAMA. 2007;297:611–9.PubMedCrossRefGoogle Scholar
  10. 10.
    DeFilippis AP, Young R, Carrubba CJ, et al. An analysis of calibration and discrimination among multiple cardiovascular risk scores in a modern multiethnic cohort. Ann Intern Med. 2015;162:266–75.PubMedPubMedCentralCrossRefGoogle Scholar
  11. 11.
    Akosah KO, Schaper A, Cogbill C, Schoenfeld P. Preventing myocardial infarction in the young adult in the first place: how do the National Cholesterol Education Panel III guidelines perform? J Am Coll Cardiol. 2003;41:1475–9.PubMedCrossRefGoogle Scholar
  12. 12.
    Cooney MT, Dudina A, Whincup P, et al., SCORE Investigators. Re-evaluating the Rose approach: comparative benefits of the population and high-risk preventive strategies. Eur J Cardiovasc Prev Rehabil. 2009;16:541–9.Google Scholar
  13. 13.
    Michos ED, Nasir K, Braunstein JB, et al. Framingham risk equation underestimates subclinical atherosclerosis risk in asymptomatic women. Atherosclerosis. 2006;184:2010–6.CrossRefGoogle Scholar
  14. 14.
    Schlendorf KH, Nasir K, Blumenthal RS. Limitations of the Framingham risk score are now much clearer. Prev Med. 2009;48:115–6.PubMedCrossRefGoogle Scholar
  15. 15.
    Blaha MJ, Silverman MG, Budoff MJ. Is there a role for coronary artery calcium scoring for management of asymptomatic patients at risk for coronary artery disease? Circ Cardiovasc Imaging. 2014;7:398–408.PubMedCrossRefGoogle Scholar
  16. 16.
    Kianoush S, Al Rifai M, Cainzos-Achirica M, et al. An update on the utility of coronary artery calcium scoring for coronary heart disease and cardiovascular disease risk prediction. Curr Atheroscler Rep. 2016;18:13.PubMedCrossRefGoogle Scholar
  17. 17.
    Bild DE, Detrano R, Peterson D, et al. Ethnic differences in coronary calcification: the Multi-Ethnic Study of Atherosclerosis. Circulation. 2005;111:1313–20.PubMedCrossRefGoogle Scholar
  18. 18.
    McClelland RL, Chung H, Detrano R, et al. Distribution of coronary artery calcium by race, gender, and age: results from the Multi-Ethnic Study of Atherosclerosis. Circulation. 2006;113:30–7.PubMedCrossRefGoogle Scholar
  19. 19.
    Cook NR. Statistical evaluation of prognostic versus diagnostic models: beyond the ROC curve. Clin Chem. 2008;54:17–23.PubMedCrossRefGoogle Scholar
  20. 20.
    Detrano R, Guerci AD, Carr JJ, et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med. 2008;358:1336–45.PubMedCrossRefGoogle Scholar
  21. 21.
    Weber LA, Cheezum MK, Reese JM, et al. Cardiovascular imaging for the primary prevention of atherosclerotic cardiovascular disease events. Curr Cardiovasc Imaging Rep. 2015;8:36.PubMedPubMedCentralCrossRefGoogle Scholar
  22. 22.
    Arad Y, Spadaro LA, Goodman K, et al. Prediction of coronary events with electron beam computed tomography. J Am Coll Cardiol. 2000;36:1253–60.PubMedCrossRefGoogle Scholar
  23. 23.
    Raggi P, Callister TQ, Cooil B, et al. Identification of patients at increased risk of first unheralded acute myocardial infarction by electron-beam computed tomography. Circulation. 2000;101:850–5.PubMedCrossRefGoogle Scholar
  24. 24.
    Wong ND, Hsu JC, Detrano RC, et al. Coronary artery calcium evaluation by electron beam tomography and its relation to new cardiovascular events. Am J Cardiol. 2000;86:495–8.PubMedCrossRefGoogle Scholar
  25. 25.
    Vliegenthart R, Oudkerk M, Song B, et al. Coronary calcification detected by electron-beam computed tomography and myocardial infraction: the Rotterdam Coronary Calcification Study. Eur Heart J. 2002;23:1596–603.PubMedCrossRefGoogle Scholar
  26. 26.
    Park R, Detrano RC, Xiang M, et al. Combined use of computed tomography coronary calcium scores and C-reactive protein levels in predicting cardiovascular events in nondiabetic individuals. Circulation. 2002;106:2073–7.PubMedCrossRefGoogle Scholar
  27. 27.
    Kondos GT, Hoff JA, Sevrukov A, et al. Electron-beam tomography coronary artery calcium and cardiac events. Circulation. 2003;107:2571–6.PubMedCrossRefGoogle Scholar
  28. 28.
    Shaw LJ, Raggi P, Schisterman E, et al. Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality. Radiology. 2003;228:826–33.PubMedCrossRefGoogle Scholar
  29. 29.
    Greenland P, LaBree L, Azen SP, et al. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA. 2004;291:210–5.PubMedCrossRefGoogle Scholar
  30. 30.
    Arad Y, Goodman KJ, Roth M, et al. Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events. J Am Coll Cardiol. 2005;46:158–65.PubMedCrossRefGoogle Scholar
  31. 31.
    Taylor AJ, Bindeman J, Feuerstein I, et al. Coronary calcium independently predicts incident premature coronary heart disease over measure cardiovascular disease risk factors. J Am Coll Cardiol. 2005;46:807–14.PubMedCrossRefPubMedCentralGoogle Scholar
  32. 32.
    Budoff MJ, Shaw LJ, Liu ST, et al. Long-term prognosis associated with coronary calcification. J Am Coll Cardiol. 2007;49:1860–70.PubMedCrossRefGoogle Scholar
  33. 33.
    Lakoski SG, Greenland P, Wong ND, et al. Coronary artery calcium scores and risk for cardiovascular events in women classified as “low risk” based on Framingham risk score. Arch Intern Med. 2007;167:2437–42.PubMedCrossRefPubMedCentralGoogle Scholar
  34. 34.
    Becker A, Leber A, Becker C, Knez A. Predictive value of coronary calcifications for future cardiac events in asymptomatic individuals. Am Heart J. 2008;155:154–60.PubMedCrossRefPubMedCentralGoogle Scholar
  35. 35.
    Erbel R, Mohlenkamp S, Moebus S, et al. Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis. J Am Coll Cardiol. 2010;56:1397–406.PubMedCrossRefPubMedCentralGoogle Scholar
  36. 36.
    Hecht HS, Narula J. Coronary artery calcium scanning in asymptomatic patients with diabetes. J Diabetes. 2012;4:342–50.PubMedCrossRefPubMedCentralGoogle Scholar
  37. 37.
    Yeboah J, McClelland RL, Polonsky TS, et al. Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. JAMA. 2012;308:788–95.PubMedPubMedCentralCrossRefGoogle Scholar
  38. 38.
    Folsom AR, Kronmal RA, Detrano RC, et al. Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: the Multi-Ethnic Study of Atherosclerosis. Arch Intern Med. 2008;168:1333–9.PubMedPubMedCentralCrossRefGoogle Scholar
  39. 39.
    Hecht HS. Coronary artery calcium scanning: past, present, and future. JACC Cardiovasc Img. 2015;8:580–96.Google Scholar
  40. 40.
    Elias-Smale SE, Vliegenthart R, Koller MT, et al. Coronary calcium score improves classification of coronary heart disease in the elderly. J Am Coll Cardiol. 2010;56:1407–14.PubMedCrossRefPubMedCentralGoogle Scholar
  41. 41.
    Stone NJ, Robinson JG, Lichtenstein AH, et al. The 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults. J Am Coll Cardiol. 2014;63:2889–934.PubMedCrossRefGoogle Scholar
  42. 42.
    Grundy SM, Stone NJ, Bailey AL, et al. 2018 ACC/AHA/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology Foundation and the American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018; https://doi.org/10.1016/j.jacc.2018.11.003.
  43. 43.
    Shaw LJ, Giambrone AE, Blaha MJ, et al. Long-term prognosis after coronary artery calcification testing in asymptomatic patients: a cohort study. Ann Intern Med. 2015;163:14–21.Google Scholar
  44. 44.
    Valenti V, Ó Hartaigh B, Heo R, et al. A 15-year warranty period for asymptomatic individuals without coronary artery calcium: a prospective follow-up of 9,715 individuals. JACC Cardiovasc Imaging. 2015;8:900–9.PubMedPubMedCentralCrossRefGoogle Scholar
  45. 45.
    Sarwar A, Shaw LJ, Shapiro MD, et al. Diagnostic and prognostic value of absence of coronary artery calcification. J Am Coll Cardiol Imaging. 2009;2:678–88.CrossRefGoogle Scholar
  46. 46.
    Polonsky TS, McClelland RL, Jorgensen NW, et al. Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA. 2010;303:1610–6.PubMedPubMedCentralCrossRefGoogle Scholar
  47. 47.
    Kelkar AA, Schultz WM, Khosa F, et al. Long-term prognosis after coronary artery calcium scoring among low-intermediate risk men and women. Circ Cardiovasc Imaging. 2016;9:e003742.  https://doi.org/10.1161/circimaging.115.003742.CrossRefPubMedGoogle Scholar
  48. 48.
    Blaha MJ, Cainzos-Achirica M, Greenland P, et al. Role of coronary artery calcium score of zero and other negative risk markers for cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation. 2016;133:849–58.PubMedPubMedCentralCrossRefGoogle Scholar
  49. 49.
    Yeboah J, Polonsky TS, Young R, et al. Utility of nontraditional risk markers in individuals ineligible for statin therapy according to the 2013 American College of Cardiology/American Heart Association cholesterol guidelines. Circulation. 2015;132:916–22.PubMedPubMedCentralCrossRefGoogle Scholar
  50. 50.
    Kavousi M, Desai CS, Ayers C, et al. Prevalence and prognostic significance of coronary artery calcification in low-risk women: a meta-analysis. JAMA. 2016;316:2126–34.PubMedCrossRefPubMedCentralGoogle Scholar
  51. 51.
    Joshi PH, Patel B, Blaha MJ, et al. Coronary artery calcium predicts cardiovascular events in participants with a low lifetime risk of cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis. 2016;246:367–73.PubMedCrossRefGoogle Scholar
  52. 52.
    Tota-Maharaj R, Blaha MJ, Blankstein R, et al. Association of coronary artery calcium and coronary heart disease events in young and elderly participants in the Multi-Ethnic Study of Atherosclerosis: a secondary analysis of a prospective, population-based cohort. Mayo Clin Proc. 2014;89:1350–9.PubMedPubMedCentralCrossRefGoogle Scholar
  53. 53.
    McClelland RL, Jorgensen NW, Budoff M, et al. 10-year coronary heart disease risk prediction using coronary artery calcium and traditional risk factors. J Am Coll Cardiol. 2015;66:1643–53.PubMedPubMedCentralCrossRefGoogle Scholar
  54. 54.
    Mortensen MB, Fuster V, Muntendam P, et al. A simple disease-guided approach to personalize ACC/AHA-recommended statin allocation in elderly people: the BioImage Study. J Am Coll Cardiol. 2016;68:881–91.PubMedCrossRefGoogle Scholar
  55. 55.
    Hoff JA, Quinn L, Sevrukov A, et al. The prevalence of coronary artery calcium among diabetic individuals without known coronary artery disease. J Am Coll Cardiol. 2003;41:1008–12.PubMedCrossRefGoogle Scholar
  56. 56.
    Daga N, Nasir K, Hamirani Y, et al. Prevalence and severity of coronary artery calcium in young persons with diabetes. J Cardiovasc Comput Tomogr. 2013;7:241–7.PubMedCrossRefPubMedCentralGoogle Scholar
  57. 57.
    Kramer CK, Ziman B, Gross JL, et al. Coronary artery calcium score prediction of all cause mortality and cardiovascular events in people with type 2 diabetes: systematic review and meta-analysis. BMJ. 2013;346:f1654.PubMedCrossRefPubMedCentralGoogle Scholar
  58. 58.
    Raggi P, Shaw LJ, Berman DS, Callister TQ. Prognostic value of coronary artery calcium screening in subjects with and without diabetes. J Am Coll Cardiol. 2004;43:1663–9.PubMedCrossRefGoogle Scholar
  59. 59.
    Malik S, Budoff MJ, Katz R, et al. Impact of subclinical atherosclerosis on cardiovascular disease events in individuals with metabolic syndrome and diabetes. Diabetes Care. 2011;34:2285–90.PubMedPubMedCentralCrossRefGoogle Scholar
  60. 60.
    Hecht HS. A zero coronary artery calcium score: priceless. J Am Coll Cardiol. 2010;55:1118–20.PubMedCrossRefPubMedCentralGoogle Scholar
  61. 61.
    Shareghi S, Ahmadi N, Young E, et al. Prognostic significance of zero coronary calcium scores on cardiac computed tomography. J Cardiovasc Comput Tomogr. 2007;1:155–9.PubMedCrossRefGoogle Scholar
  62. 62.
    Pencina MJ, Navar-Boggan AM, D’Agostino RB Sr, et al. Application of new cholesterol guidelines to a population-based sample. N Engl J Med. 2014;370:1422–31.PubMedCrossRefGoogle Scholar
  63. 63.
    Blaha M, Budoff MJ, Shaw LJ, et al. Absence of coronary artery calcification and all-cause mortality. J Am Coll Cardiol Img. 2009;2:692–700.CrossRefGoogle Scholar
  64. 64.
    Budoff MJ, McClelland RL, Nasir K, et al. Cardiovascular events with absent or minimal coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA). Am Heart J. 2009;158:554–61.PubMedPubMedCentralCrossRefGoogle Scholar
  65. 65.
    Nasir K, Bittencourt MS, Blaha MJ, et al. Implications of coronary artery calcium testing among statin candidates according to American College of Cardiology/American Heart Association cholesterol management guidelines. J Am Coll Cardiol. 2015;66:1657–68.PubMedCrossRefGoogle Scholar
  66. 66.
    Ridker PM, Danielson E, Fonseca FA, et al., for the JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359:2195–202.Google Scholar
  67. 67.
    Blaha MJ, Budoff MJ, DeFilippis AP, et al. Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort study. Lancet. 2001;378:684–92.CrossRefGoogle Scholar
  68. 68.
    Valenti V, Hartaigh BO, Cho I, et al. Absence of coronary artery calcium identifies asymptomatic diabetic individuals at low near-term but not long-term risk of mortality: a 15-year follow-up study of 9715 patients. Circ Cardiovasc Imaging. 2016;9:e003528.  https://doi.org/10.1161/CIRCIMAGING.115.003528.CrossRefPubMedPubMedCentralGoogle Scholar
  69. 69.
    Nasir K, Rubin J, Blaha MJ, et al. Interplay of coronary artery calcification and traditional risk factors for the prediction of all-cause mortality in asymptomatic individuals. Circ Cardiovasc Imaging. 2012;5:467–73.PubMedCrossRefGoogle Scholar
  70. 70.
    Silverman MG, Blaha MJ, Krumholz HM, et al. Impact of coronary artery calcium on coronary heart disease events in individuals at the extremes of traditional risk factor burden: the Multi-Ethnic Study of Atherosclerosis. Eur Heart J. 2014;35:2232–41.PubMedCrossRefGoogle Scholar
  71. 71.
    Martin SS, Blaha MJ, Blankstein R, et al. Dyslipidemia, coronary artery calcium, and incident atherosclerotic cardiovascular disease: implications for statin therapy from the Multi-Ethnic Study of Atherosclerosis. Circulation. 2014;129:77–86.PubMedCrossRefGoogle Scholar
  72. 72.
    National Cholesterol Education Program. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): final report. Circulation. 2002;106:3149–421.Google Scholar
  73. 73.
    Agarwal S, Morgan T, Herrington DM, et al. Coronary calcium score and prediction of all-cause mortality in diabetes. Diabetes Care. 2001;34:1219–24.CrossRefGoogle Scholar
  74. 74.
    Budoff MJ, Diamond GA, Raggi P, et al. Continuous probabilistic prediction of angiographically significant coronary artery disease using electron beam tomography. Circulation. 2002;105:1791–6.PubMedCrossRefGoogle Scholar
  75. 75.
    Villines TC, Julten EA, Shaw LJ, et al., for the CONFIRM Registry Investigators. Prevalence and severity of coronary artery disease and adverse events among symptomatic patients with coronary artery calcification scores of zero undergoing coronary computed tomography angiography. J Am Coll Cardiol. 2011;58:2533–40.Google Scholar
  76. 76.
    Lubbers M, Dedic A, Coenen A, et al. Calcium imaging and selective computed tomography angiography in comparison to functional testing for suspected coronary artery disease: the multicenter, randomized CRESCENT trial. Eur Heart J. 2016;37:1232.  https://doi.org/10.1093/eurheartj/ehv700.CrossRefPubMedGoogle Scholar
  77. 77.
    Kim YJ, Hur J, Lee HJ, et al. Meaning of zero calcium score in symptomatic patients referred for coronary computed tomography. Eur Heart J Cardiovasc Imaging. 2012;13:776–85.PubMedCrossRefGoogle Scholar
  78. 78.
    Wolk MJ, Bailey SR, Doherty JU, et al. ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2103 Multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease. J Am Coll Cardiol. 2014;63:381–406.CrossRefGoogle Scholar
  79. 79.
    Greenland P. When nothing is really something. JACC Cardiovasc Imaging. 2015;8:910–2.PubMedCrossRefGoogle Scholar
  80. 80.
    Taylor AJ, Raggi J, Raggi P. The power of nothing: the zero calcium score. J Cardiovasc Comput Tomogr. 2007;1:160–1.PubMedCrossRefGoogle Scholar
  81. 81.
    McEvoy JW, Martin SS, Blaha MJ, et al. The case for and against a coronary artery calcium trial. JACC Cardiovasc Imaging. 2016;9:994–1002.PubMedCrossRefGoogle Scholar
  82. 82.
    Rozanski A, Gransar H, Shaw LJ, et al. Impact of coronary artery calcium scanning on coronary risk factors and downstream testing. The EISNER (Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research) prospective randomized trial. J Am Coll Cardiol. 2011;57:1622–32.PubMedPubMedCentralCrossRefGoogle Scholar
  83. 83.
    Mamudu HM, Paul TK, Veeranki SP, Budoff M. The effects of coronary artery calcium screening on behavioral modification, risk perception, and medication adherence among asymptomatic adults. Atherosclerosis. 2014;236:338–50.PubMedCrossRefGoogle Scholar
  84. 84.
    Orakzai RH, Nasir K, Orakzai SH, et al. Effect of patient visualization of coronary calcium by electron beam computed tomography on changes in beneficial lifestyle changes. Am J Cardiol. 2008;101:999–1002.PubMedCrossRefGoogle Scholar
  85. 85.
    Taylor AJ, Bindeman J, Feuerstein I, et al. Community-based provision of statin and aspirin after the detection of coronary artery calcium within a community-based screening cohort. J Am Coll Cardiol. 2008;51:1337–41.PubMedCrossRefGoogle Scholar
  86. 86.
    Kalia NK, Cespedes L, Youssef G, et al. Motivational effects of coronary artery calcium scores on statin adherence and weight loss. Coron Artery Dis. 2015;26:226–30.CrossRefGoogle Scholar
  87. 87.
    McEvoy JW, Blaha MJ. Coronary artery calcium testing: exploring the need for a randomized trial. Circ Cardiovasc Imaging. 2014;7:578–80.PubMedCrossRefGoogle Scholar
  88. 88.
    Kim J, McEvoy JW, Nasir K, et al. Critical review of high-sensitivity C-reactive protein and coronary artery calcium for the guidance of statin allocation. Circ Cardiovasc Imaging. 2014;7:315–22.Google Scholar
  89. 89.
    Institute of Medicine. Clinical practice guidelines we can trust. Available at https://www.nap.edu/read/13058/chapter/1. Accessed 4 Feb 2017.
  90. 90.
    ROBINSCA Study Design. Available at http://www.robinsca.nl/for-researchers/study-design/. Accessed 4 Feb 2017.
  91. 91.
    Budoff MJ, Young R, Lopez VA, et al. Progression of coronary calcium and incident coronary heart disease events: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol. 2013;61:1231–9.PubMedPubMedCentralCrossRefGoogle Scholar
  92. 92.
    Budoff MJ, Hokanson JE, Nasir K, et al. Progression of coronary artery calcium predicts all-cause mortality. JACC Cardiovas Imaging. 2010;3:1229–36.CrossRefGoogle Scholar
  93. 93.
    Wong ND, Nelson JC, Granston T, et al. Metabolic syndrome, diabetes, and incidence and progression of coronary calcium. JACC Cardiovasc Imaging. 2012;5:358–66.PubMedPubMedCentralCrossRefGoogle Scholar
  94. 94.
    Erbel R, Lehmann N, Churzidse S, et al., on behalf of the Heinz Nixdorf Recall Study Investigators. Progression of coronary artery calcification seems to be inevitable, but predictable—results of the Heinz Nixdorf Recall (HNR) study. Eur Heart J. 2014;35:2960–2971.Google Scholar
  95. 95.
    Raggi P, Callister TQ, Shaw LJ. Progression of coronary artery calcium and risk of first myocardial infarction in patients receiving cholesterol-lowering therapy. Arterioscler Thromb Vasc Biol. 2004;24:1272–7.PubMedCrossRefPubMedCentralGoogle Scholar
  96. 96.
    McCullough PA, Chinnaiyan KM. Annual progression of coronary calcification in trials of preventive therapies: a systematic review. Arch Intern Med. 2009;169:2064–70.PubMedCrossRefGoogle Scholar
  97. 97.
    Nissen SE, Nicholls SJ, Sipahi I, et al. Effects of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA. 2006;295:1556–65.PubMedCrossRefGoogle Scholar
  98. 98.
    Nicholls SJ, Ballantyne CM, Barter PJ, et al. Effect of two intensive statin regimens on progression of coronary disease. N Engl J Med. 2001;365:2078–87.CrossRefGoogle Scholar
  99. 99.
    Ferencik M, Chatzizisis YS. Statins and the coronary plaque calcium “paradox”: insights from non-invasive and invasive imaging. Atherosclerosis. 2015;241:783–5.PubMedCrossRefGoogle Scholar
  100. 100.
    McElvoy JW, Blaha MJ, DeFilippis AP, et al. Coronary artery calcium progression: an important clinical measurement? J Am Coll Cardiol. 2010;56:1613–22.CrossRefGoogle Scholar
  101. 101.
    Houslay ED, Cowell SJ, Prescott RJ, et al. Progressive coronary calcification despite intensive lipid-lowering treatment: a randomized controlled trial. Heart. 2006;92:1207–12.PubMedPubMedCentralCrossRefGoogle Scholar
  102. 102.
    Raggi P, Davidson M, Callister TQ, et al. Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women: beyond endorsed lipid lowering with EBT scanning (BELLES). Circulation. 2005;112:563–71.PubMedCrossRefGoogle Scholar
  103. 103.
    Arad Y, Spadaro LA, Roth M, et al. Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C, and vitamin E: the St. Francis Heart Study Randomized Clinical Trial. J Am Coll Cardiol. 2005;46:166–72.PubMedCrossRefGoogle Scholar
  104. 104.
    Puri R, Nicholls SJ, Shao M, et al. Impact of statin serial coronary calcification during atheroma progression and regression. J Am Coll Cardiol. 2015;65:1273–82.PubMedCrossRefGoogle Scholar
  105. 105.
    Raber L, Taniwaki M, Zaugg S, et al. Effect of high-intensity statin therapy on atherosclerosis in non-infarct-related coronary arteries (IBIS-4): a serial intravascular ultrasonography study. Eur Heart J. 2015;36:490–500.PubMedCrossRefGoogle Scholar
  106. 106.
    O’Rourke RA, Brundage BH, Froelicher VF, et al. American College of Cardiology/American Heart Association Expert Consensus Document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. Circulation. 2000;102:126–40.PubMedCrossRefGoogle Scholar
  107. 107.
    Greenland P, Abrams J, Aurigemma GP, et al. Prevention Conference V. Beyond secondary prevention: identifying the high-risk patient for primary prevention. Noninvasive tests of atherosclerotic burden. Circulation. 2000;101:e16–322.PubMedCrossRefGoogle Scholar
  108. 108.
    Mieres JH, Shaw LJ, Arai A, et al. Role of noninvasive testing in the clinical evaluation women with suspected coronary artery disease. Consensus Statement from the Cardiac Imaging Committee, Council on Clinic Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart Association. Circulation. 2005;111:682–96.PubMedCrossRefGoogle Scholar
  109. 109.
    Budoff MJ, Achenbach S, Blumenthal RS, et al. Assessment of coronary artery disease by cardiac computed tomography. AHA scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology. Circulation. 2006;114:1761–91.PubMedCrossRefGoogle Scholar
  110. 110.
    Greenland P, Bonow RO, Brundage BH, et al. ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain. A report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to update the 2000 Expert Consensus Document on electron beam computed tomography). Circulation. 2007;115:402–26.PubMedCrossRefGoogle Scholar
  111. 111.
    Detrano RC, Anderson M, Nelson J, Wong ND, et al. Coronary calcium measurements: effect of CT scanner type and calcium measure on rescan reproducibility—MESA study. Radiology. 2005;236:477–84.PubMedCrossRefGoogle Scholar
  112. 112.
    Greenland P, Bonow RO, Brundage BH, et al. ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography) developed in collaboration with the Society of Atherosclerosis Imaging and Prevention and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol. 2007;49:378–402.PubMedCrossRefPubMedCentralGoogle Scholar
  113. 113.
    Greenland P, Smith SC Jr, Grundy SM. Improving coronary heart disease risk assessment in asymptomatic people: role of traditional risk factors and noninvasive cardiovascular tests. Circulation. 2001;104:1863–7.PubMedCrossRefGoogle Scholar
  114. 114.
    Greenland P, Alpert JS, Beller GA, et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults. J Am Coll of Cardiol. 2010;56:e50–103.CrossRefGoogle Scholar
  115. 115.
    Earls JP, Woodard PK, Abbara S, et al. ACR appropriateness criteria asymptomatic patient at risk for coronary artery disease. J Am Coll Radiol. 2014;11:12–9.PubMedCrossRefGoogle Scholar
  116. 116.
    Piepoli MF, Hoes AW, Agewall S, et al. 2016 European guidelines on cardiovascular disease prevention in clinical practice. The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on cardiovascular disease prevention in clinical practice. Eur Heart J. 2016;37:2315–81.PubMedPubMedCentralCrossRefGoogle Scholar
  117. 117.
    Berrington de Gonzalex A, Mahesh M, Kim KP, et al. Projected cancer risks from computed tomographic scans performed in the United States in 2007. Arch Intern Med. 2009;169:2071–7.CrossRefGoogle Scholar
  118. 118.
    Moyer VA, on behalf of the U.S. Preventive Services Task Force. Screening for lun cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;160:330–8.Google Scholar
  119. 119.
    Hecht HS, Cronin P, Blaha MJ, et al. 2016 SCCT/STR guidelines for coronary artery calcium scoring of noncontrast noncardiac chest CT scans: a report of the Society of Cardiovascular Computed Tomography and Society of Thoracic Radiology. J Cardiovasc Comput Tomogr. 2017;  https://doi.org/10.1016/j.jcct.2016.11.003.
  120. 120.
    Budoff MJ, Nasir K, Kinney GL, et al. Coronary artery and thoracic calcium on non-contrast thoracic CT scans: comparison of ungated and gated examinations in patients from the COPD gene cohort. J Cardiovasc Comput Tomogr. 2011;5:113–8.PubMedCrossRefGoogle Scholar
  121. 121.
    Hughes-Austin JM, Dominquez A, Allison MA, et al. Relationship of coronary artery calcium on standard chest computed tomography scans with mortality. J Am Coll Cardiol Img. 2016;9:152–9.CrossRefGoogle Scholar
  122. 122.
    Jacob PC, Prokop M, van der Graaf Y, et al. Comparing coronary artery calcium and thoracic aorta calcium for prediction of all-cause mortality and cardiovascular events on low-dose non-gated computed tomography in high-risk population of heavy smokers. Atherosclerosis. 2010;209:455–62.CrossRefGoogle Scholar
  123. 123.
    Mmets OM, Vliegenthart R, Gondrie MJ, et al. Lung cancer screening CT-based prediction of cardiovascular events. J Am Coll Cardiol Img. 2013;6:899–907.CrossRefGoogle Scholar
  124. 124.
    Lung Cancer Screening Registry. American College of Radiology. Available at https://www.acr.org/~/media/ACR/Documents/PDF/QualitySafety/NRDR/Lung-Cancer-Screening-Practice-Registry/ACR-LCSR-User-Guide.pdf?la=en. Accessed 1 Apr 2017.

Copyright information

© Humana Press 2019

Authors and Affiliations

  1. 1.Seinsheimer Cardiovascular Health Program, Department of Medicine and CardiologyMedical University of South CarolinaCharlestonUSA
  2. 2.Department of Medicine, Division of Cardiovascular MedicineOregon Health & Science UniversityPortlandUSA

Personalised recommendations